Phibro Animal Health | PAHC - Net Income


Phibro Animal Health reported $27.46M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Align Technology USD 108.29M 4.48M Jun/2026
ANI Pharmaceuticals USD 24.71M 4.78M Jun/2026
Aurora Cannabis CAD -71.1M 72.92M Mar/2026
Bristol-Myers Squibb USD 3.32B 640M Jun/2026
Canopy Growth CAD -157.11M 94.49M Mar/2026
Corcept Therapeutics USD 42.14M 73.9M Jun/2026
Eli Lilly USD 7.1B 301M Jun/2026
Henry Schein USD 94M 13M Jun/2026
Idexx Laboratories USD 338.41M 59.97M Jun/2026
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Merck USD -1.34B 2.9B Jun/2026
Nektar Therapeutics USD -44.9M 8.82M Mar/2026
Pacira USD 4.65M 1.74M Jun/2026
Phibro Animal Health USD 27.46M 932K Dec/2025
Prestige Brands USD 38.54M 15.39M Jun/2026
Supernus Pharmaceuticals USD -58.37M 56.08M Jun/2026
Zoetis USD 691M 90M Jun/2026